Entrepreneur Abandons De-Aging Drug Experiment Amid Concerns Over Unintended Consequences

Bryan Johnson, the billionaire founder of OS Fund and entrepreneur known for his pursuit of longevity, has made a shocking admission. In a recent post, he revealed that he has discontinued using a de-aging drug due to concerns that it may have actually aged him instead.

As a self-proclaimed “longevity obsessive,” Johnson has been at the forefront of the quest for eternal youth. He’s invested heavily in his own health and wellness, including undergoing extensive testing and trying various treatments to extend his lifespan.

However, his latest experiment appears to have backfired. In a post on his personal blog, he wrote that he had been using a de-aging drug, but after taking it for some time, he noticed disturbing changes in his body.

“I’ve decided to stop taking this treatment,” Johnson said in the post. “I’m not going to sugarcoat it: I don’t feel good. I don’t feel like myself.”

Johnson didn’t specify what kind of de-aging drug he was using or provide any concrete evidence to support his claims, but the admission raises questions about the effectiveness and potential risks associated with these treatments.

As someone who has dedicated a significant portion of his life to researching longevity and aging, this sudden shift in stance may come as a surprise to many. It’s unclear what led him to stop using the drug or if he will continue exploring other options for achieving eternal youth.

In the meantime, Johnson’s decision serves as a stark reminder that even those with seemingly unlimited resources and access to cutting-edge technology are not immune to the complexities of human biology.

It remains to be seen how this development will impact the longevity community and whether others will follow in his footsteps.

Source: gizmodo.com